135 related articles for article (PubMed ID: 3112074)
21. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
22. [The effect of 3'-azido-3'-deoxynucleosides on the reproduction of AIDS virus in cell culture].
Galegov GA; Korneeva MN; Nosik DN; Kilesso TIu; Kraevskiĭ AA
Mol Biol (Mosk); 1988; 22(3):802-6. PubMed ID: 2460737
[TBL] [Abstract][Full Text] [Related]
23. Acute effects of 3'-azido-3'-deoxythymidine on the cell cycle of HL60 cells.
Roskrow M; Wickramasinghe SN
Clin Lab Haematol; 1990; 12(2):177-84. PubMed ID: 2208948
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of HIV-1 replication and antigen expression in EBV-transformed B cell lines.
Tremblay M; Fitz-Gibbon L; Wainberg MA
Leukemia; 1988 Dec; 2(12 Suppl):233S-240S. PubMed ID: 2849000
[TBL] [Abstract][Full Text] [Related]
25. AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system.
Torrence PF; Kinjo J; Lesiak K; Balzarini J; De Clercq E
FEBS Lett; 1988 Jul; 234(1):135-40. PubMed ID: 3164686
[TBL] [Abstract][Full Text] [Related]
26. Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
Richman DD
Antimicrob Agents Chemother; 1987 Dec; 31(12):1879-81. PubMed ID: 3501941
[TBL] [Abstract][Full Text] [Related]
27. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
28. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR
In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722
[TBL] [Abstract][Full Text] [Related]
29. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
Smith MS; Brian EL; Pagano JS
J Virol; 1987 Dec; 61(12):3769-73. PubMed ID: 2446006
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
Spector SA; Ripley D; Hsia K
Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
[TBL] [Abstract][Full Text] [Related]
32. Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine.
Medina DJ; Tung PP; Lerner-Tung MB; Nelson CJ; Mellors JW; Strair RK
J Virol; 1995 Mar; 69(3):1606-11. PubMed ID: 7853495
[TBL] [Abstract][Full Text] [Related]
33. The role of interferon-gamma in antiretroviral activity of methionine enkephalin and AZT in a murine cell culture.
Sin JI; Specter S
J Pharmacol Exp Ther; 1996 Dec; 279(3):1268-73. PubMed ID: 8968350
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
[TBL] [Abstract][Full Text] [Related]
35. Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs.
Hartmann H; Vogt MW; Durno AG; Hirsch MS; Hunsmann G; Eckstein F
AIDS Res Hum Retroviruses; 1988 Dec; 4(6):457-66. PubMed ID: 3219235
[TBL] [Abstract][Full Text] [Related]
36. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus.
Mitchell WM; Montefiori DC; Robinson WE; Strayer DR; Carter WA
Lancet; 1987 Apr; 1(8538):890-2. PubMed ID: 2882293
[TBL] [Abstract][Full Text] [Related]
37. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells.
Dainiak N; Worthington M; Riordan MA; Kreczko S; Goldman L
Br J Haematol; 1988 Jul; 69(3):299-304. PubMed ID: 3261597
[TBL] [Abstract][Full Text] [Related]
38. Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity.
Sommadossi JP; Carlisle R; Schinazi RF; Zhou Z
Antimicrob Agents Chemother; 1988 Jul; 32(7):997-1001. PubMed ID: 3190201
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.
Smith MS; Brian EL; De Clercq E; Pagano JS
Antimicrob Agents Chemother; 1989 Sep; 33(9):1482-6. PubMed ID: 2479334
[TBL] [Abstract][Full Text] [Related]
40. A pro-drug of zidovudine with enhanced efficacy against human immunodeficiency virus.
Gogu SR; Aggarwal SK; Rangan SR; Agrawal KC
Biochem Biophys Res Commun; 1989 Apr; 160(2):656-61. PubMed ID: 2719688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
